Compound 21 Induces Vasorelaxation via an Endothelium- and Angiotensin II Type 2 Receptor-Independent Mechanism
- 1 September 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 60 (3), 722-729
- https://doi.org/10.1161/hypertensionaha.112.196022
Abstract
Angiotensin II type 2 (AT 2 ) receptor stimulation has been linked to vasodilation. Yet, AT 2 receptor-independent hypertension and hypotension (or no effect on blood pressure) have been observed in vivo after application of the AT 2 receptor agonist compound 21 (C21). We, therefore, studied its effects in vitro, using preparations known to display AT 2 receptor-mediated responses. Hearts of Wistar rats, spontaneously hypertensive rats (SHRs), C57Bl/6 mice, and AT 2 receptor knockout mice were perfused according to Langendorff. Mesenteric and iliac arteries of these animals, as well as coronary microarteries from human donor hearts, were mounted in Mulvany myographs. In the coronary vascular bed of Wistar rats, C57Bl/6 mice, and AT 2 receptor knockout mice, C21 induced constriction followed by dilation. SHR hearts displayed enhanced constriction and no dilation. Irbesartan (angiotensin II type 1 receptor blocker) abolished the constriction and enhanced or (in SHRs) reintroduced dilation, and PD123319 (AT 2 receptor blocker) did not block the latter. C21 relaxed preconstricted vessels of all species, and this did not depend on angiotensin II receptors, the endothelium, or the NO-guanylyl cyclase-cGMP pathway. C21 constricted SHR iliac arteries but none of the other vessels, and irbesartan prevented this. C21 shifted the concentration-response curves to U46619 (thromboxane A 2 analog) and phenylephrine (α-adrenoceptor agonist) but not ionomycine (calcium ionophore) to the right. In conclusion, C21 did not cause AT 2 receptor-mediated vasodilation. Yet, it did induce vasodilation by blocking calcium transport into the cell and constriction via angiotensin II type 1 receptor stimulation. The latter effect is enhanced in SHRs. These data may explain the varying effects of C21 on blood pressure in vivo.Keywords
This publication has 32 references indexed in Scilit:
- A Nonpeptide Angiotensin II Type 2 Receptor Agonist Does Not Attenuate Postmyocardial Infarction Left Ventricular Remodeling in MiceJournal of Cardiovascular Pharmacology, 2012
- Direct Stimulation of Angiotensin II Type 2 Receptor Enhances Spatial MemoryJournal of Cerebral Blood Flow & Metabolism, 2011
- Gender Differences in Pressure-Natriuresis and Renal AutoregulationHypertension, 2011
- Angiotensin AT 2 Receptor Stimulation Inhibits Early Renal Inflammation in Renovascular HypertensionHypertension, 2011
- Stimulation of angiotensin AT2 receptors by the non‐peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive ratsBritish Journal of Pharmacology, 2010
- Effects of Angiotensin Metabolites in the Coronary Vascular Bed of the Spontaneously Hypertensive RatHypertension, 2010
- Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damageJournal of Hypertension, 2009
- Angiotensin Type 2 Receptor in Resistance Arteries of Type 2 Diabetic Hypertensive PatientsHypertension, 2007
- AT2receptor-mediated vasodilation in the mouse heart depends on AT1Areceptor activationBritish Journal of Pharmacology, 2006
- Renal Angiotensin Type 2 Receptors Mediate Natriuresis Via Angiotensin III in the Angiotensin II Type 1 Receptor–Blocked RatHypertension, 2006